Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1038083.RAvQdyYBCsrG9-hW8nN3zTQA0rKc2-YSFTBiRvZiqf4NE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1038083.RAvQdyYBCsrG9-hW8nN3zTQA0rKc2-YSFTBiRvZiqf4NE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1038083.RAvQdyYBCsrG9-hW8nN3zTQA0rKc2-YSFTBiRvZiqf4NE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1038083.RAvQdyYBCsrG9-hW8nN3zTQA0rKc2-YSFTBiRvZiqf4NE130_provenance.
- NP1038083.RAvQdyYBCsrG9-hW8nN3zTQA0rKc2-YSFTBiRvZiqf4NE130_assertion description "[We found that anisomycin treatment (10-15 nM) alone had no effect on the level of apoptosis, but a combination treatment of anisomycin and TRAIL significantly increased the level of apoptosis in human renal carcinoma (Caki, ACHN and A498), human glioma (U251MG), and human breast carcinoma (MDA-MB-361 and MCF7) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1038083.RAvQdyYBCsrG9-hW8nN3zTQA0rKc2-YSFTBiRvZiqf4NE130_provenance.
- NP1038083.RAvQdyYBCsrG9-hW8nN3zTQA0rKc2-YSFTBiRvZiqf4NE130_assertion evidence source_evidence_literature NP1038083.RAvQdyYBCsrG9-hW8nN3zTQA0rKc2-YSFTBiRvZiqf4NE130_provenance.
- NP1038083.RAvQdyYBCsrG9-hW8nN3zTQA0rKc2-YSFTBiRvZiqf4NE130_assertion SIO_000772 23261849 NP1038083.RAvQdyYBCsrG9-hW8nN3zTQA0rKc2-YSFTBiRvZiqf4NE130_provenance.
- NP1038083.RAvQdyYBCsrG9-hW8nN3zTQA0rKc2-YSFTBiRvZiqf4NE130_assertion wasDerivedFrom befree-2016 NP1038083.RAvQdyYBCsrG9-hW8nN3zTQA0rKc2-YSFTBiRvZiqf4NE130_provenance.
- NP1038083.RAvQdyYBCsrG9-hW8nN3zTQA0rKc2-YSFTBiRvZiqf4NE130_assertion wasGeneratedBy ECO_0000203 NP1038083.RAvQdyYBCsrG9-hW8nN3zTQA0rKc2-YSFTBiRvZiqf4NE130_provenance.
- befree-2016 importedOn "2016-02-19" NP1038083.RAvQdyYBCsrG9-hW8nN3zTQA0rKc2-YSFTBiRvZiqf4NE130_provenance.